Senior insider sale
Chief Business Officer at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$1.20M
16.39K shares
What this filing means
BAROLDI JOSEPH plans to sell 16.39K shares of IONIS PHARMACEUTICALS INC valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001972481-26-000080
Officer· Chief Business Officer
Since Jan 2022
16.39K
Shares to sell
$1.20M
Approx. market value
4.10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
1/15/2022
4.10KTotal acquired4.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2022 | Restricted Stock Units Equity Compensation | 4.10K | — |
| Total | 4.10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.30K
Market value
$439.7K
1/30/2026
—Completed
Units to sell
7K
Market value
$439.7K
1/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.10K
Market value
$325.1K
3/3/2026
Total
Units
16.39K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/30/2026 | 5.30K | $439.7K | — | Completed |
1/16/2026 | 7K | $439.7K | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 4.10K | $325.1K | Nasdaq | Planned |
| Total | 16.39K | $1.20M | ||